| A Pilot Study of RNS60 in Amyotrophic Lateral Sclerosis (ALS) (NCT02525471) | Sabrina Paganoni, M.D. | 2015-10-01 |
| Identification of Drug-drug Interaction Between Tacrolimus and Mycophenolate Mofetil in Healthy Adults (NCT02743247) | Seoul National University Hospital | 2015-10-01 |
| Transplantation of HUC-MSCs With Injectable Collagen Scaffold for POF (NCT02644447) | Chinese Academy of Sciences | 2015-10-01 |
| Kinesiotape Tensiomyography in Low Back Region (NCT02735408) | Universidad Europea de Madrid | 2015-10-01 |
| Effect of BM-MSCs in DCD Kidney Transplantation (NCT02561767) | First Affiliated Hospital, Sun Yat-Sen University | 2015-10-01 |
| Human Umbilical Cord-derived Mesenchymal Stem Cells With Injectable Collagen Scaffold Transplantation for Chronic Ischemic Cardiomyopathy (NCT02635464) | Chinese Academy of Sciences | 2015-10-01 |
| Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fasting Conditions (NCT03696329) | Dr. Reddy's Laboratories Limited | 2015-10-01 |
| T-DM1 and Non-pegylated Liposomal Doxorubicin in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (NCT02562378) | MedSIR | 2015-10-01 |
| Fluorescence Guided Surgery in Breast Cancer (NCT02583568) | University Medical Center Groningen | 2015-10-01 |
| Vaccination of Advanced-Stage Lung Cancer Patients (NCT02264236) | University of Arkansas | 2015-10-01 |
| Study of DS-5141b in Patients With Duchenne Muscular Dystrophy (NCT02667483) | Daiichi Sankyo Co., Ltd. | 2015-10-01 |
| The Effect of Dairy and Non-dairy Breakfasts on Satiety and Post-meal Glycemia in Healthy Older Adults (NCT02607007) | University of Toronto | 2015-10-01 |
| A Pharmacokinetic-pharmacodynamic Dose Comparison Study of 8 mg/kg of Inhaled or Parenteral Gentamicin in 12 Mechanically Ventilated Critically Ill Patients Treated for Ventilator-associated Pneumonia (NCT02515448) | Poitiers University Hospital | 2015-10-01 |
| Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Intravenously to Healthy Adult Volunteers (NCT02636049) | Rockwell Medical Technologies, Inc. | 2015-10-01 |
| Effects of Lepidium Meyenii Walp on Sexual Function in Postmenopausal Women (NCT02624648) | Universidade do Vale do Sapucai | 2015-10-01 |
| Phase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly Subjects (NCT02546310) | Nxera Pharma UK Limited | 2015-10-01 |
| Effect of Vitamin d Deficiency in Chronic Rhinosinusitis With Nasal Polyposis (NCT04529668) | Ain Shams University | 2015-10-01 |
| Renal Function During Pediatric Anesthesia (NCT02571426) | Uppsala University | 2015-10-01 |
| Determine the Bioequivalence of Two Formulations of Hyoscine Butylbromide. (NCT02516098) | Boehringer Ingelheim | 2015-10-01 |
| Safety and Dose Ranging Study of Human Insulin Receptor MAb-IDUA Fusion Protein in Adults and Children With MPS I (NCT03053089) | ArmaGen, Inc | 2015-10-01 |
| Dose Escalation of OXi4503 as Single Agent and Combination With Cytarabine w/Subsequent Ph 2 Cohorts for AML and MDS (NCT02576301) | Mateon Therapeutics | 2015-10-01 |
| Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors (NCT02502708) | NewLink Genetics Corporation | 2015-10-01 |
| Amendment of rTSST-1 Variant Vaccine Phase 1 Clinical Trial (NCT02971670) | Biomedizinische Forschungs gmbH | 2015-10-01 |
| Food Effect Study of AG120 in Healthy Subjects (NCT02579707) | Agios Pharmaceuticals, Inc. | 2015-10-01 |
| Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid Tumors (NCT02648711) | NewLink Genetics Corporation | 2015-10-01 |
| Root Coverage Using a Xenograph for Treatment of Gingival Recession (NCT02657395) | Mayo Clinic | 2015-10-01 |
| Study of Neo-adjuvant RO7009789 Alone or Neo-adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine Followed by Adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine for Patients With Newly Diagnosed Resectable Pancreatic Carcinoma (NCT02588443) | Abramson Cancer Center at Penn Medicine | 2015-10-01 |
| Safety and Immunogenicity of the RSV D46cpΔM2-2 Vaccine in RSV-Seropositive Children and RSV-Seronegative Infants and Children (NCT02601612) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-10-01 |
| A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer (NCT02543645) | Celldex Therapeutics | 2015-10-01 |
| Nabilone in Cannabis Users With PTSD (NCT03251326) | New York State Psychiatric Institute | 2015-10-01 |
| Suprasacral Parallel Shift - Ultrasound/MR Image Fusion Guided Lumbosacral Plexus Block (NCT02593370) | Thomas F. Bendtsen | 2015-10-01 |
| Enterotoxigenic Escherichia Coli (ETEC) ETVAX Vaccine Trial in Bangladesh (NCT02531802) | PATH | 2015-10-01 |
| Abatacept for SLE Arthritis (IM101-330) (NCT02429934) | University of California, Los Angeles | 2015-10-01 |
| Fentanyl Sublingual Spray and Fentanyl Citrate Intravenous (IV) in Opioid Naive Subjects (NCT02576353) | INSYS Therapeutics Inc | 2015-10-01 |
| IVF in Pediatric Concussion (NCT02214316) | Washington University School of Medicine | 2015-10-01 |
| Study of HTD4010 in Healthy Volunteers (NCT02538848) | HighTide Therapeutics (Hong Kong) Limited | 2015-10-01 |
| A Study in Healthy Volunteers to Assess the Effect of Fedovapagon on the QT/QTC Interval (NCT02537288) | Vantia Ltd | 2015-10-01 |
| Pilot Study of Vigil™ + Pembrolizumab for Advanced Melanoma (NCT02574533) | Gradalis, Inc. | 2015-10-01 |
| Subcutaneous Immunotherapy for Mouse in Adults (NCT02532179) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-10-01 |
| 18F-AV-1451 PET Imaging in TBI (NCT02512029) | Avid Radiopharmaceuticals | 2015-10-01 |
| A Study to Investigate How the Study Drug SHP626 is Eliminated From the Body After One Dose (NCT02571192) | Mirum Pharmaceuticals, Inc. | 2015-10-01 |
| Trial of Oxaloacetate in Alzheimer's Disease (TOAD) (NCT02593318) | Russell Swerdlow | 2015-10-01 |
| A Study To Investigate The Absorption, Distribution, Metabolism, And Excretion Of [14c]PF-06463922 In Healthy Male Volunteers (NCT02564562) | Pfizer | 2015-10-01 |
| Variable Frequency Stimulation of Subthalamic Nucleus for Freezing of Gait in Parkinson's Disease (NCT02601144) | Beijing Pins Medical Co., Ltd | 2015-10-01 |
| Mannitol Cream for Post Herpetic Neuralgia (NCT02484170) | University of British Columbia | 2015-09-30 |
| Study of Isatuximab Combined With Bortezomib + Cyclophosphamide + Dexamethasone (VCD) and Bortezomib + Lenalidomide + Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) Non Eligible for Transplant or No Intent for Immediate Transplantation (NCT02513186) | Sanofi | 2015-09-30 |
| Pembrolizumab and Afatinib in Patients With Non-small Cell Lung Cancer With Resistance to Erlotinib (NCT02364609) | Jonathan Riess | 2015-09-30 |
| Phase 1/2 Study of the Safety and Efficacy of Rociletinib in Combination With Trametinib in Patients With mEGFR-positive Advanced or Metastatic Non-small Cell Lung Cancer (NCT02580708) | Clovis Oncology, Inc. | 2015-09-30 |
| Single Ascending Doses of BIIB063 in Healthy Volunteers (NCT02555085) | Biogen | 2015-09-30 |
| Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma (NCT02530502) | Northwestern University | 2015-09-30 |
| A Drug Interaction Study of Lanabecestat (LY3314814) and Warfarin in Healthy Participants (NCT02540668) | AstraZeneca | 2015-09-30 |
| A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease (NCT02562768) | Eli Lilly and Company | 2015-09-30 |
| A Study of Atezolizumab Administered Alone or in Combination With Azacitidine in Participants With Myelodysplastic Syndromes (NCT02508870) | Hoffmann-La Roche | 2015-09-30 |
| Methoxyamine Hydrochloride, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer (NCT02535325) | National Cancer Institute (NCI) | 2015-09-30 |
| Dapivirine Gel Rectal Safety and PK Study (NCT03044379) | International Partnership for Microbicides, Inc. | 2015-09-29 |
| Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy (NCT02427581) | Washington University School of Medicine | 2015-09-29 |
| Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of BI 1026706 in Healthy Male Subjects (NCT02513446) | Boehringer Ingelheim | 2015-09-29 |
| Gene Therapy Study in Severe Haemophilia A Patients (270-201) (NCT02576795) | BioMarin Pharmaceutical | 2015-09-28 |
| Effects of Doravirine (MK-1439) on Methadone Pharmacokinetics in Methadone-Maintained Participants (MK-1439-045) (NCT02715700) | Merck Sharp & Dohme LLC | 2015-09-28 |
| Phase I/II Trial of Alectinib and Bevacizumab in Patients With Advanced, Anaplastic Lymphoma Kinase (ALK)-Positive, Non-Small Cell Lung Cancer (NCT02521051) | Massachusetts General Hospital | 2015-09-28 |
| Gingival Crevicular Fluid Levels of Protein Carbonyl Following the Use of Lycopene in Chronic Periodontitis (NCT03203746) | Maie Sami tawfik | 2015-09-28 |
| Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma (NCT02561273) | University of Nebraska | 2015-09-28 |
| A Pharmacologic Study of CYC065, a Cyclin Dependent Kinase Inhibitor, in Patients With Advanced Cancers (NCT02552953) | Cyclacel Pharmaceuticals, Inc. | 2015-09-28 |
| Multiple Ascending Dose Study of ALZ-801 (NCT04157712) | Alzheon Inc. | 2015-09-26 |
| A Study to Characterize the Elimination of Guselkumab Glycoform Variants in Healthy Participants (NCT02570373) | Janssen Research & Development, LLC | 2015-09-25 |
| Study of Pharmacodynamic Equivalence of Enoxaparin Rovi to Clexane®, in Healthy Volunteers (NCT03363477) | Rovi Pharmaceuticals Laboratories | 2015-09-25 |
| 5-Way Crossover Study to Compare the Safety, Tolerability and Pharmacokinetics of New Oral Cannabinoid Formulations Administered as Single Doses, With Buccal Sativex®, in Healthy Volunteers (NCT03201835) | PhytoTech Therapeutics, Ltd. | 2015-09-24 |
| Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation (NCT02356159) | National Cancer Institute (NCI) | 2015-09-24 |
| A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants (NCT02566759) | Neurocrine Biosciences | 2015-09-23 |
| A Phase 1/2 Study of MEDI4276 in Adults Subjects With Select HER2-expressing Advanced Solid Tumors. (NCT02576548) | MedImmune LLC | 2015-09-23 |
| A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplification (NCT02468661) | Novartis Pharmaceuticals | 2015-09-23 |
| INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme (NCT02386826) | SCRI Development Innovations, LLC | 2015-09-22 |
| A Two-part Single- and Repeat-dose Study of CSJ137 in Anemic Chronic Hemodialysis Patients (NCT02570854) | Novartis Pharmaceuticals | 2015-09-22 |
| A Study to Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV (NCT02495246) | University of Oxford | 2015-09-21 |
| Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma (NCT02619357) | GlaxoSmithKline | 2015-09-21 |
| Bioavailability of Doravirine (MK-1439) Experimental Nano Formulations in Healthy Adults (MK-1439-046) (NCT02549040) | Merck Sharp & Dohme LLC | 2015-09-21 |
| An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B (NCT02554773) | Genzyme, a Sanofi Company | 2015-09-18 |
| Study of Immunotherapy in Combination With Ublituximab and Umbralisib in Patients With Relapsed-refractory CLL or Richter's Transformation (NCT02535286) | TG Therapeutics, Inc. | 2015-09-18 |
| A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX) (NCT02630368) | Institut Bergonié | 2015-09-18 |
| ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors (NCT02565758) | AbbVie | 2015-09-18 |
| Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer (NCT02444741) | M.D. Anderson Cancer Center | 2015-09-17 |
| A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel (NCT02656043) | Xenon Pharmaceuticals Inc. | 2015-09-17 |
| A Study to Evaluate the Pharmacokinetics of Oral Formulations of MMV390048 Administered Fasted to Healthy Volunteers (NCT02554799) | Medicines for Malaria Venture | 2015-09-17 |
| A Study of Islatravir (MK-8591) in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus-1 Infected Participants (MK-8591-003) (NCT02217904) | Merck Sharp & Dohme LLC | 2015-09-17 |
| A Dose-Ranging Study of IPH2201 in Patients With Gynecologic Malignancies (NCT02459301) | Canadian Cancer Trials Group | 2015-09-17 |
| A Bioequivalence Study of Pegylated Interferon Alfa-2a (PEG-IFN Alfa-2a) Benzyl Alcohol (BA)-Free Formulation Versus PEG-IFN Alfa-2a (Pegasys) Following Subcutaneous Administration (NCT02573025) | Hoffmann-La Roche | 2015-09-17 |
| A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(U.S. and German Sourced) in Healthy Chinese Male Subjects (NCT02581748) | Shanghai Henlius Biotech | 2015-09-16 |
| Single Dose Study of ALZ-801 Prototype Tablets (NCT04585347) | Alzheon Inc. | 2015-09-16 |
| A Phase I/II Safety, Tolerability, Immunogenicity, and Bioactivity Study of DE-122 Injectable Solution for Refractory Exudative Age-related Macular Degeneration (NCT02555306) | Santen Inc. | 2015-09-16 |
| A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia (NCT02516306) | Encore Vision, Inc. | 2015-09-16 |
| A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005) (NCT02531373) | Merck Sharp & Dohme LLC | 2015-09-15 |
| A Study to Determine the Safety, Tolerability, and Pharmacokinetics of GDC-0310 in Healthy Volunteers (NCT02742779) | Genentech, Inc. | 2015-09-15 |
| Metabolism and Pharmacokinetics of [14C]-BI 409306 After Administration as Oral Solution in Healthy Male Volunteers (NCT02597998) | Boehringer Ingelheim | 2015-09-15 |
| A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) (NCT02500407) | Genentech, Inc. | 2015-09-15 |
| Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy (NCT02516813) | EMD Serono Research & Development Institute, Inc. | 2015-09-15 |
| Effect of Concomitant Use of an Antimycotic, an Antibiotic, a Spermicide or Tampons on Pharmacokinetics of Anastrozole and Levonorgestrel Released From Intra-vaginal Ring (NCT02545452) | Bayer | 2015-09-15 |
| Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 655130 in Healthy Male Volunteers (NCT02525679) | Boehringer Ingelheim | 2015-09-14 |
| Safety, Tolerability and Pharmacokinetics (PK) Study of Oxytocin (GR121619) Administered Via an Inhaled Route in Healthy Female Volunteers (NCT02542813) | GlaxoSmithKline | 2015-09-14 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-42847922 in Healthy Japanese Male Participants (NCT02555124) | Janssen Pharmaceutical K.K. | 2015-09-12 |
| GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1) (NCT02528357) | GlaxoSmithKline | 2015-09-11 |